Have a personal or library account? Click to login

Relationship between quality of life indicators and cardiac status indicators in chemotherapy patients

Open Access
|Oct 2021

References

  1. Strongman H, Gadd S, Matthews A, Mansfield KE, Stanway S, Lyon AR, et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked uk electronic health records databases. Lancet. 2019;394(10203):1041-54. doi: 10.1016/S0140-6736(19)31674-5.
  2. Coviello JS. Cardiovascular and cancer risk: the role of cardio-oncology. J Adv Pract Oncol. 2018;9(2):160-76. doi: 10.6004/jadpro.2018.9.2.
  3. Krzyszczyk P, Acevedo A, Davidoff EJ, Timmins LM, Marrero-Berrios I, Patel M, et al. The growing role of precision and personalized medicine for cancer treatment. Technology (Singap World Sci). 2018;6(3-4):79-100. doi: 10.1142/S2339547818300020.
  4. Page RL 2nd, O’Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, et al. Drugs that may cause or exacerbate heart failure: a scientific statement from the american heart association. 2016;134(12):e261. Circulation. 2016;134(6):e32-69. doi: 10.1161/CIR.0000000000000426.
  5. Marinko T, Dolenc J, Bilban-Jakopin C. Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer. Radiol Oncol. 2014;48(2):105-12. doi: 10.2478/raon-2013-0040.
  6. Alvarez JA, Russell RR. Cardio-oncology: the nuclear option. Curr Cardiol Rep. 2017;19(4):31. doi: 10.1007/s11886-017-0844-z.
  7. Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the quality-of-life questionnaire c30. J Clin Oncol. 2004;22(17):3485-90. doi: 10.1200/JCO.2004.03.025.
  8. Grašič Kuhar C, Gortnar Cepeda T, Kovač T, Kukar M, Ružić Gorenjec N. Mobile app for symptom management and associated quality of life during systemic treatment in early stage breast cancer: nonrandomized controlled prospective cohort study. JMIR Mhealth Uhealth. 2020;8(8):e17408. doi: 10.2196/17408.
  9. Drafts BC, Twomley KM, D’Agostino R Jr, Lawrence J, Avis N, Ellis LR, et al. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. JACC Cardiovasc Imaging. 2013;6(8):877-85. doi: 10.1016/j.jcmg.2012.11.017.
  10. Giusca S, Korosoglou G, Montenbruck M, Geršak B, Schwarz AK, Esch S, et al. Multiparametric early detection and prediction of cardiotoxicity using myocardial strain, t1 and t2 mapping and biochemical markers: a longitudinal cardiac resonance imaging study during two years of follow-up. Circ Cardiovasc Imaging. 2021;14:e012459. doi: 10.1161/ CIRCIMAGING.121.012459.
  11. Curigliano G, Cardinale D, Suter T, Plataniotis G, de Azambuja E, Sandri MT, et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: esmo clinical practice guidelines. Ann Oncol. 2012;23(Suppl 7):vii155-66. doi: 10.1093/annonc/mds293.
  12. Balestroni G, Bertolotti G. EuroQol-5D (EQ-5D): an instrument for measuring quality of life. Monaldi Arch Chest Dis. 2012;78(3):155-9. doi: 10.4081/monaldi.2012.121.
  13. Eq-5d-5l user guide: basic information on how to use the eq-5d-5l instrument. Accessed March 30th, 2021 at: https://euroqol.org/wp-content/uploads/2019/09/EQ-5D-5L-English-User-Guide_version-3.0-Sept-2019-secured.pdf
  14. Eq-5d (euroqol) • definition | gabler wirtschaftslexikon. Accessed February 27th, 2021 at: https://wirtschaftslexikon.gabler.de/definition/eq-5d-euroqol-51755
  15. Hinz A, Kohlmann T, Stöbel-Richter Y, Zenger M, Brähler E. The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population. Qual Life Res. 2014;23(2):443-7. doi: 10.1007/s11136-013-0498-2.
  16. SF-36 Health survey: manual & interpretation guide. Accessed March 30th, 2021 at: https://www.researchgate.net/publication/313050850_SF-36_Health_Survey_Manual_Interpretation_Guide
  17. Sf-36 | springerlink. Accessed March 30th, 2021 at: https://link.springer.com/referenceworkentry/10.1007%2F978-1-4419-1005-9_1597
  18. Ellert U, Bellach BM. Der sf-36 im bundes-gesundheitssurvey - beschreibung einer aktuellen normstichprobe. Gesundheitswesen. 1999;61:S184-90.
  19. Koos R, Altiok E, Doetsch J, Neizel M, Krombach G, Marx N, et al. Layer-specific strain-encoded mri for the evaluation of left ventricular function and infarct transmurality in patients with chronic coronary artery disease. Int J Cardiol. 2013;166(1):85-9. doi: 10.1016/j. ijcard.2011.10.004.
  20. Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and The European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2014;15(10):1063-93. doi: 10.1093/ehjci/jeu192.
  21. Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 esc position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the esc committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the european society of cardiology (esc). Eur Heart J. 2016;37(36):2768-801. doi: 10.1093/ eurheartj/ehw211.
  22. Petek D, Petek-Ster M, Tusek-Bunc K. Health behavior and health-related quality of life in patients with a high risk of cardiovascular disease. Zdr Varst. 2018;57(1):39-46. doi: 10.2478/sjph-2018-0006.
  23. Prevolnik Rupel V, Ogorevc M, IMPACT HTA HRQoL Group. EQ-5D-Y value set for Slovenia. Pharmacoeconomics. 2021;39(4):463-71. doi: 10.1007/s40273-020-00994-4.
  24. Prevolnik Rupel V, Srakar A, Rand K. Valuation of EQ-5D-3l health states in Slovenia: VAS based and TTO based value sets. Zdr Varst. 2020;59(1):8-17. doi: 10.2478/sjph-2020-0002.
  25. Schneider JE, Stojanovic I. Economic evaluation of cardiac magnetic resonance with fast-senc in the diagnosis and management of early heart failure. Health Econ Rev. 2019;9(1):13. doi: 10.1186/s13561-019-0229-7.
  26. Thavendiranathan P, Wintersperger BJ, Flamm SD, Marwick TH. Cardiac MRI in the assessment of cardiac injury and toxicity from cancer chemotherapy: a systematic review. Circ Cardiovasc Imaging. 2013;6(6):1080-91. doi: 10.1161/CIRCIMAGING.113.000899.
DOI: https://doi.org/10.2478/sjph-2021-0028 | Journal eISSN: 1854-2476 | Journal ISSN: 0351-0026
Language: English
Page range: 199 - 209
Submitted on: Mar 9, 2021
Accepted on: Mar 31, 2021
Published on: Oct 20, 2021
Published by: National Institute of Public Health, Slovenia
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2021 Blaž Matija Geršak, Andreja Kukec, Henning Steen, Moritz Montenbruck, Maja Šoštarič, Arne Kristian Schwarz, Sebastian Esch, Sebastian Kelle, Sorin Giusca, Grigorios Korosoglou, Pia Wülfing, Susan Dent, Daniel Lenihan, published by National Institute of Public Health, Slovenia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.